A preliminary analysis of Wuchereria bancrofti microfilarial antigens for potential use in diagnosis.

Several antigens from the microfilarial stage of Wuchereria bancrofti have been identified using immunoblots of microfilarial antigens and screening with immune sera and tropical pulmonary eosinophilia (TPE) sera. This analysis revealed an array of antigens with apparent molecular weights of 14kDa, 35kDa, 42kDa, 63kDa, 88kDa, 97kDa and 200kDa. Among these only the 14kDa and 42kDa antigens were consistently recognized by most of the immune sera. A 132kDa antigen was recognized only by TPE sera. Analysis of rabbit immune sera revealed that the 42kDa antigen was shared by two developmental stages of W. bancrofti, namely L3 and mF. This antigen could become a potential vaccine candidate. The 14kDa antigen seems specific for the microfilarial stage and therefore could be a diagnostic marker for active infection. The 132kDa antigen could aid in the diagnosis of TPE.

Comparative efficacy of single dose anthelmintics in relation to intensity of geohelminth infections.

The efficacy of a single dose of albendazole 400 mg, levamisole 2.5 mg/kg, mebendazole 500 mg, mebendazole 200 mg and pyrantel pamoate 10 mg/kg was evaluated in relation to the intensity of infection of Ascaris lumbricoides, Necator americanus and Trichuris trichiura. The study group comprised 667 3 to 12 year old children from poorer segments of the community. All 5 treatments produced high egg reduction rates ranging from 95.9% to 99.7% and substantial cure rates for Ascaris infection; the differences observed in the 5 treatment groups were not significant (p greater than 0.05). Although all treatment groups were effective against Necator, the number of patients was too small to draw useful conclusions. In Trichuris infections, although higher cure rates were obtained in light compared to heavy infections, the results were uniformly poor in all treatment groups. The few side effects encountered were mild and did not require any intervention.

HLA and filariasis in Sri Lankans and Indians.

Similar HLA association was found in patients with elephantiasis in Sri Lankans and Southern Indians. HLA-B15 was observed in 13/44 (30%) Sri Lankan patients with elephantiasis compared to 1/27 (4%) Sri Lankan controls (p = .0058; RR = 10.9) and in 5/8 (28%) Southern Indian elephantiasis compared to 10/101 (10%) Southern Indian controls (p = 0.04; RR = 3.5). In combining the data, the significance of the difference of the frequency of B15 between patients with elephantiasis and controls was even more marked (p = 0.00045; corrected p = 0.012; RR = 4.4).

Detection of filarial antibodies in Malayan and Bancroftian filariasis by the indirect fluorescent antibody test, using different filarial antigens.

Indirect fluorescent antibody tests (IFAT) using Wuchereria bancrofti infective larvae as antigen had the highest positivity rates in detecting Malayan and Bancroftian filariasis as compared to IFAT using antigens prepared from 5 other animal filarial species, Brugia pahangi, Dirofilaria immitis, Dipetalonema viteae, Litomosoides carinii and Onchocerca gutturosa. This study also recommends the use of human filarioids as the source of antigen in serological tests. However, before B. malayi and especially W. bancrofti can be easily available from the common laboratory animals. B. pahangi seems to be a suitable source of antigen for use in serological tests for human lymphatic filariasis.

Detection of circulating antigens and immune complexes in feline and human lymphatic filariasis.

Circulating worm antigens were detected in 61% to 81% of sera from Brugia pahangi -infected cats and in 0-93% of sera from humans with malayan of bancroftian filariasis by counter immunoelectrophoresis and a double antibody sandwich enzyme-linked immunosorbent assay, using rabbit antisera to B. pahangi adult worms. In some situations, both antigen tests were as sensitive as antibody tests. However, ELISA was likely to be affected by the presence of antiglobulins, such as rheumatoid factor, in the test sera. Only 10% to 22% of B. pahangi-infected cats (treated with drugs or not) had circulating immune complexes by the conglutinin-binding assay and no sera were positive by C1q-BA. A significantly higher percentage (56%) of B. malayi clinical sera was positive for immune complexes by either C1q- or conglutinin- binding assays as compared to other groups of B. malayi and Wuchereria bancrofti sera (6% to 14%).